Literature DB >> 29122894

Dyspnoea in lupus.

Jeremy Fleri Soler1, Andrew Borg2, Cecilia Mercieca2.   

Abstract

A 32-year-old woman suffering from systemic lupus erythematosus presented with a 6-week history of progressive dyspnoea and pleuritic chest pain. Examination was normal apart from reduced air entry at the lung bases.Arterial blood gases showed hypoxaemia and chest X-ray revealed raised hemidiaphragms without any pleural effusions. Lung function showed a restrictive pathology while high-resolution chest CT and CT pulmonary angiogram were negative. Echocardiography showed normal ventricular diameters and no pericardial effusion. Reduced lung volumes and a positive fluoroscopic sniff test lead to a diagnosis of shrinking lung syndrome. Symptoms improved following treatment with glucocorticoids and non-invasive ventilation, but there was no change in lung function.A year later, our patient presented again with worsening dyspnoea. This time echocardiography revealed severe mitral stenosis with pulmonary hypertension. Mitral valve replacement was performed and dyspnoea resolved. Histology showed Libman-Sachs endocarditis. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  lung function; mechanical ventilation; systemic lupus erythematosus; valvar diseases

Mesh:

Year:  2017        PMID: 29122894      PMCID: PMC5695324          DOI: 10.1136/bcr-2017-220162

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  The respiratory system in connective tissue disorders.

Authors:  B Crestani
Journal:  Allergy       Date:  2005-06       Impact factor: 13.146

2.  Shrinking lung syndrome in systemic lupus erythematosus successfully treated with rituximab.

Authors:  R P Goswami; S Mondal; D Lahiri; K Basu; S Das; P Ghosh; A Ghosh
Journal:  QJM       Date:  2016-06-17

Review 3.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

Review 4.  Lung disease related to collagen vascular disease.

Authors:  David A Lynch
Journal:  J Thorac Imaging       Date:  2009-11       Impact factor: 3.000

Review 5.  Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review.

Authors:  Sophie P Toya; George E Tzelepis
Journal:  Semin Arthritis Rheum       Date:  2008-06-30       Impact factor: 5.532

6.  Antiphospholipid Syndrome and Libman-Sacks Endocarditis in a Bioprosthetic Mitral Valve.

Authors:  Eric H Sladek; Kevin D Accola
Journal:  Ann Thorac Surg       Date:  2016-02       Impact factor: 4.330

Review 7.  Cardiac manifestations of systemic lupus erythematosus.

Authors:  Jonathan J Miner; Alfred H J Kim
Journal:  Rheum Dis Clin North Am       Date:  2014-02       Impact factor: 2.670

8.  Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus.

Authors:  L Fidler; K J Keen; Z Touma; S Mittoo
Journal:  Lupus       Date:  2016-02-03       Impact factor: 2.911

9.  Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution.

Authors:  Ioannis Moyssakis; Maria G Tektonidou; Vassilios A Vasilliou; Michael Samarkos; Vassilios Votteas; Haralampos M Moutsopoulos
Journal:  Am J Med       Date:  2007-07       Impact factor: 4.965

Review 10.  Mitral valve surgery in patients with systemic lupus erythematosus.

Authors:  Mahnoosh Foroughi; Manouchehr Hekmat; Mohsen Ghorbani; Hamid Ghaderi; Masoud Majidi; Mahmood Beheshti
Journal:  ScientificWorldJournal       Date:  2014-10-14
View more
  1 in total

Review 1.  Respiratory Manifestations in Systemic Lupus Erythematosus.

Authors:  Salvatore Di Bartolomeo; Alessia Alunno; Francesco Carubbi
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.